Wojciech Michalak

4PUBLICATIONS
8CO-AUTHORS
Nutritional epidemiologyEndocrinologyGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 01, 2026
Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.

|Apr 28, 2026
Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE).

|Jun 28, 2025
Impact of semaglutide 2.4 mg on healthcare resource utilization and medical costs in patients with atherosclerotic cardiovascular disease in the United States (SHINE-ASCVD).

Wojciech Michalak, Zhenxiang Zhao, Mads Faurby

|Mar 23, 2025
Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months).

Aleksandrina Ruseva, Firas Dabbous, Nina Ding

Pageof 1

Frequent Collaborators

2 joint publications

Zhenxiang Zhao

1 joint publications

Aleksandrina Ruseva

1 joint publications

Firas Dabbous

1 joint publications

Anthony Fabricatore